Myriad Genetics (MYGN) Interest Coverage Ratio Growth (1y) (2010 - 2026)
Myriad Genetics (MYGN) Interest Coverage Ratio Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 14.65% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 3.80% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -91.18% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 120.45% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -7.61% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 97.40% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -28.45% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -11.26% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.67% |
| 10 | Myriad Genetics | 297.97 Mn | 173.57 Mn | 137.60 Mn | -5.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.86% |
| Dec 31, 2025 | -101.27% |
| Sep 30, 2025 | -127.99% |
| Jun 30, 2025 | -10,843.27% |
| Mar 31, 2025 | 92.58% |
| Dec 31, 2024 | 472.61% |
| Sep 30, 2024 | -45.54% |
| Jun 30, 2024 | 99.12% |
| Mar 31, 2024 | -3,172.68% |
| Sep 30, 2023 | -30.54% |
| Jun 30, 2023 | -666.52% |
| Mar 31, 2023 | 97.69% |
| Sep 30, 2022 | 99.20% |
| Jun 30, 2022 | -185.26% |
| Mar 31, 2022 | -82.73% |
| Dec 31, 2021 | 267.48% |
| Sep 30, 2021 | -149.54% |
| Jun 30, 2021 | 72.20% |
| Mar 31, 2021 | 73.22% |
| Dec 31, 2020 | -330.05% |